Dextran sulfate and stromal cell derived factor-1 enhance the expression of CXCR4 and improve the homing efficiency of hematopoletic stem cells in bone marrow
硫酸葡聚糖和基质细胞衍生因子1增强CXCR4表达并提高骨髓造血干细胞归巢效率
基本信息
- 批准号:14570780
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Homing of hematopoietic stem cells (HSCs) in bone marrow (BM) is an important step of hematopoietic development and bone marrow repopulation. It is postulated that the circulating HSCs interact with BM endothelial cells, extravasate, and finally reach the specialized BM micrenvironment called "niches'. Although various kinds of chemokines, cytokines, and adhesion molecules supposed to be involved, the mechanism of HSC homing is not fully understood. Recent studies suggested that interaction of the chemokine receptor CXCR4 and its ligand, stromnal derived factor 1 (SDF-1) plays critical roles in multiple steps of HSC homing. In addition, it was reported that dextran sulfate (DEX) increased plasma levels of SDF1 and HSCs in mice and non-human primates. In this study, we examined the effects of preconditioning with SDF1 and DEX on the homing efficiency of HSCs during BM transplantation. SDF-1 (100ng/kg), DEX (100mg/kg), or PBS was injected into donor GFP transgenic mice 4 times for 4 cons … More ecutive days before harvesting BM cells. Quantitative RP-PCR analysis showed CXCR4 expression on GFP+BM cells was increased in both SDF-1 and DEX treated mice. DEX pretreatment also increased the levels of homing related molecules including MMP9, E-selectin, VEGF, VLA5, and LFA1 in BM cells harvested from the donor mice. Flow cytometry analysis demonstrated that the reconstitution efficiencies at 7 days after BM transplantation were significantly higher with BM cells from SDF-1 treated (45.1±10.1%) and DEX6 treated mice (72.3±7.1%) comnpored to control mice (35.2±1.6%)(n=3). The DEX mediated enhancement of reconstitution at an early stage was also observed in peripheral blood, thymus and spleen. However, the differences became not significant 30 days after BM transplantation. These results indicate that both SDF-1 and DEX are capable of enhancement of HSC homing SDF-1 may directly upregulate CXCR4 expression on HSCs, widle DEX appears to multiple functions including induction of SDF-1 and other molecules required for homing. Preconditioning with DEX may offer a novel clinical approach to improve homing and engraftment of HSCs. Less
造血干细胞(hematopoietic stem cells,HSCs)在骨髓中的归巢是造血发育和骨髓再增殖的重要环节。据推测,循环的HSC与BM内皮细胞相互作用,外渗,并最终到达称为“小生境”的特化BM微增强。虽然各种趋化因子、细胞因子和粘附分子可能参与了HSC归巢,但其机制尚未完全清楚。最近的研究表明,趋化因子受体CXCR 4及其配体基质衍生因子1(SDF-1)的相互作用在HSC归巢的多个步骤中起着关键作用。此外,据报道,硫酸葡聚糖(DEX)增加了小鼠和非人灵长类动物中SDF 1和HSC的血浆水平。在这项研究中,我们研究了SDF 1和DEX预处理对骨髓移植过程中HSC归巢效率的影响。将SDF-1(100 ng/kg)、DEX(100 mg/kg)或PBS注射到供体GFP转基因小鼠体内,共4次,持续4周。 ...更多信息 在收获BM细胞之前的连续几天。定量RP-PCR分析显示,在SDF-1和DEX处理的小鼠中,GFP+BM细胞上的CXCR 4表达增加。DEX预处理还增加了从供体小鼠收获的BM细胞中归巢相关分子的水平,包括MMP 9、E-选择素、VEGF、VLA 5和LFA 1。流式细胞术分析表明,骨髓移植后7天,SDF-1处理组和DEX 6处理组小鼠骨髓细胞的重建效率(45.1±10.1%)(72.3±7.1%)显著高于对照组小鼠(35.2±1.6%)(n=3)。在外周血、胸腺和脾脏中也观察到DEX介导的早期重建增强。然而,骨髓移植后30天的差异变得不显著。这些结果表明,SDF-1和DEX都能够增强HSC归巢,SDF-1可能直接上调HSC上CXCR 4的表达,广泛的DEX似乎具有多种功能,包括诱导SDF-1和归巢所需的其他分子。DEX预处理可能为改善HSC归巢和植入提供一种新的临床方法。少
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hayakawa J, Migita M, Ueda T, Shimada T, Fukunaga Y: "Generation of a chimeric mouse reconstituted with green fluorescent protein-positive bone marrow cells : a useful model for studying the behavior of bone marrow cells in regeneration in vivo."Int J Hem
Hayakawa J、Migita M、Ueda T、Shimada T、Fukunaga Y:“用绿色荧光蛋白阳性骨髓细胞重建的嵌合小鼠的产生:研究骨髓细胞体内再生行为的有用模型。”Int
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hayakawa J, Migita M et al.: "Generation of a chimeric mouse reconstituted with green fluorescent protein-positive bone marrow cells : a useful model for studying the behavior of bone marrow cells in regeneration in vivo."Int.J.Hematol. 77. 456-462 (2003)
Hayakawa J、Migita M 等人:“用绿色荧光蛋白阳性骨髓细胞重建嵌合小鼠的产生:研究骨髓细胞体内再生行为的有用模型。”Int.J.Hematol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUKUNAGA Yoshitaka其他文献
FUKUNAGA Yoshitaka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUKUNAGA Yoshitaka', 18)}}的其他基金
Research on the development of the Emperor's rule system in the Former Han dynasty,focusing on personality bond
前汉皇帝统治制度的发展研究——以人格纽带为中心
- 批准号:
17K13551 - 财政年份:2017
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
相似国自然基金
牙龈卟啉单胞菌激活CAFs调控SDF-1/CXCR4通路促进食管癌进展及免疫逃逸的机制研究
- 批准号:82302966
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
硝酸盐通过SDF-1/CXCR4轴调控EPCs归巢与巨噬细胞串扰减轻糖尿病组织瓣缺血损伤的作用及机制研究
- 批准号:82370925
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SDF-1/CXCR4在肾小球疾病足细胞及系膜细胞交流中的作用及机制
- 批准号:2023JJ30546
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
三七总皂苷基于SDF-1/CXCR4信号轴介导骨髓间充质干细胞归巢调控成骨分化及血管再生干预骨质疏松性骨折的研究
- 批准号:82360938
- 批准年份:2023
- 资助金额:32.00 万元
- 项目类别:地区科学基金项目
年轻骨髓干细胞通过SDF-1/CXCR4促进年老小鼠心脏自噬修复心脏功能的分子机制研究
- 批准号:n/a
- 批准年份:2023
- 资助金额:10.0 万元
- 项目类别:省市级项目
七氟醚通过SDF-1/CXCR4信号通路影响中间神经元切向迁徙的机制研究
- 批准号:22ZR1410500
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
CXCR4/SDF-1轴在肺鳞癌免疫治疗中的作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于SDF-1/CXCR4轴募集内源性骨髓间充质干细胞探讨电针联合VEGF微球治疗周围神经损伤的机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于外泌体miR-1246介导SDF-1/CXCR4信号通路探讨桂枝芍药知母汤调控RA软骨基质代谢平衡的作用机制
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
miR-430多靶点抑制在前列腺癌骨转移中对SDF-1/CXCR4/CXCR7轴的调控机制
- 批准号:n/a
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Determining the role of the SDF-1/CXCR4 pathway and its intersection with chronic stress to establish novel precision approaches to head and neck cancer management
确定 SDF-1/CXCR4 通路的作用及其与慢性应激的交叉点,以建立头颈癌管理的新型精准方法
- 批准号:
10642091 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
CXCR4/SDF-1 axis ameliorates the impaired wound healing and tissue regeneration in aged periodontal tissue
CXCR4/SDF-1轴改善老化牙周组织中受损的伤口愈合和组织再生
- 批准号:
22K09963 - 财政年份:2022
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immunological analysis of the efficacy of SDF-1/CXCR4 inhibitors in idiopathic pulmonary fibrosis
SDF-1/CXCR4抑制剂治疗特发性肺纤维化疗效的免疫学分析
- 批准号:
22K08239 - 财政年份:2022
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
頭頸部扁平上皮癌におけるCXCR4/SDF-1軸の役割の解析
CXCR4/SDF-1轴在头颈部鳞癌中的作用分析
- 批准号:
20K18241 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Facilitating meniscus healing through SDF-1/CXCR4 axis modified cell-therapy
通过 SDF-1/CXCR4 轴修饰细胞疗法促进半月板愈合
- 批准号:
10132243 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
BMP9の歯周組織におけるSDF-1/CXCR4 axisを中心とした機能の解明
阐明BMP9在牙周组织中以SDF-1/CXCR4轴为中心的功能
- 批准号:
18K17100 - 财政年份:2018
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanism of meniscal healing and clinical application through SDF-1/CXCR4 signaling pathway
SDF-1/CXCR4信号通路的半月板愈合机制及临床应用
- 批准号:
16K10871 - 财政年份:2016
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of metabotropic glutamate receptor 5 expression by the miR-30 downregulation induced by the SDF-1/CXCR4 system in oral cancer cells.
口腔癌细胞中 SDF-1/CXCR4 系统诱导的 miR-30 下调对代谢型谷氨酸受体 5 表达的调节。
- 批准号:
26861725 - 财政年份:2014
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
SDF-1/CXCR4シグナルを標的とした乳癌骨転移に対する新規治療法の開発
开发针对 SDF-1/CXCR4 信号的乳腺癌骨转移新疗法
- 批准号:
25462006 - 财政年份:2013
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of miRNA on the mechanism of metastasis induced by the SDF-1/CXCR4 system in oral cancer
miRNA在SDF-1/CXCR4系统诱导口腔癌转移机制中的作用
- 批准号:
23592964 - 财政年份:2011
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)